News & Events

Mouse

Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
Press Release

Jan
6

2021
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
Press Release

Dec
9

2020
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
Press Release

Aug
5

2020
Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima.
Press Release

Aug
4

2020
Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development
Press Release

Nov
19

2019
Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma.
Press Release

Jun
18

2019
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
Press Release

Feb
27

2019
Genesis Biotechnology Group announces partnership with Yale University
Press Release

Oct
30

2018
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
Press Release

Jul
19

2018
Experimental Autoimmune Encephalomyelitis Model
Press Release

Apr
27

2018
Invivotek Maintains Full AAALAC Accreditation for Excellence in Animal Care and Use
Press Release

Sep
14

2017
Invivotek Completes Solar Farm and Facility Expansion
Press Release

Mar
27

2017
Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
Press Release

Mar
1

2017
Invivotek Awarded Full AAALAC Accreditation for Excellence in Animal Care and Use
Press Release

Jul
14

2014
Invivotek Receives Distinguished Innovation and Achievement Award from Allentown, Inc., the Leader in Design and Installation for Quality Animal Housing
Press Release

Nov
20

2013